Polymeric micelles with small lipophilic moieties for drug delivery

Colloids and Surfaces B: Biointerfaces

Volumn 116, Issue , 2014, Pages 627-632

  Li, Dong ^a   Liang, Yan ^a   Lai, Yusi ^a   Wang, Gang ^a   He, Bin ^a   Gu, Zhongwei ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

9 nitro 20(s) camptothecin; Cellular uptake; Cytotoxicity; Drug delivery; Micelle

Indexed keywords

AMINO ACIDS; BODY FLUIDS; CRITICAL MICELLE CONCENTRATION; CYTOTOXICITY; DRUG DELIVERY; DYNAMIC LIGHT SCATTERING; ETHYLENE GLYCOL; TRANSMISSION ELECTRON MICROSCOPY;

ANTICANCER ACTIVITIES; CAMPTOTHECIN (CPT); CELLULAR UPTAKE; CRITICAL MICELLE CONCENTRATION (CMC); DELIVERY SYSTEMS; LIVER CANCER CELLS; POLYMERIC MICELLE; RELEASE PROFILES;

MICELLES;

CINNAMIC ACID; HISTIDINE; METHOXYPOLY(ETHYLENE GLYCOL); METHOXYPOLY(ETHYLENE GLYCOL)HISTIDINE DI(CINNAMIC ACID); NANOCARRIER; RUBITECAN; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; CAMPTOTHECIN; MICELLE; POLYMER;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL STRAIN HEPG2; CONTROLLED STUDY; CRITICAL MICELLE CONCENTRATION; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG SOLUBILITY; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG UPTAKE; ENCAPSULATION; IC 50; IN VITRO STUDY; LIGHT SCATTERING; LIPOPHILICITY; MICELLE; PARTICLE SIZE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; TRANSMISSION ELECTRON MICROSCOPY; ANALOGS AND DERIVATIVES; CELL PROLIFERATION; CELL SURVIVAL; CHEMICAL PHENOMENA; CHEMICAL STRUCTURE; CHEMISTRY; DOSE RESPONSE; DRUG EFFECTS; DRUG SCREENING; HEPG2 CELL LINE; HUMAN; STRUCTURE ACTIVITY RELATION; SYNTHESIS;

ANTINEOPLASTIC AGENTS; CAMPTOTHECIN; CELL PROLIFERATION; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG DELIVERY SYSTEMS; DRUG SCREENING ASSAYS, ANTITUMOR; HEP G2 CELLS; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; MICELLES; MOLECULAR STRUCTURE; POLYMERS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84898792364     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2013.10.032     Document Type: Article

References (41)

1. Torchilin V. Pharmaceut. Res. 2007, 24:1-16.
2. Fan L., Li F., Zhang H., Wang Y., Cheng C., Li X., Gu C., Yang Q., Wu H., Zhang S. Biomaterials 2010, 31:5634-5642.
3. Lee A.L.Z., Wang Y., Cheng H.Y., Pervaiz S., Yang Y.Y. Biomaterials 2009, 30:919-927.
4. Wang H., Zhao P., Su W., Wang S., Liao Z., Niu R., Chang J. Biomaterials 2010, 31:8741-8748.
5. Saad M., Garbuzenko O.B., Minko T. Nanomedicine 2008, 3:761-776.
6. Jenekhe S.A., Chen X.L. Science 1998, 279:1903-1907.
7. Lo C.L., Lin K.M., Hsiue G.H. J. Controlled Release 2005, 104:477-488.
8. Gaucher G., Dufresne M.H., Sant V.P., Kang N., Maysinger D., Leroux J.C. J. Controlled Release 2005, 109:169-188.
9. Couvreur P., Kante B., Grislain L., Roland M., Speiser P. J. Pharm. Sci. 1982, 71:790-792.
10. Gao Y., Chen L., Gu W., Xi Y., Lin L., Li Y. Mol. Pharm. 2008, 5:1044-1054.
11. Kwon G.S. Crit. Rev. Ther. Drug. Carrier Syst. 2003, 20:357.
12. Tang N., Du G., Wang N., Liu C., Hang H., Liang W. J. Natl. Cancer I 2007, 99:1004-1015.
13. Maeda H. Adv. Drug Delivery Rev. 2001, 46:169-185.
14. Maeda H., Seymour L.W., Miyamoto Y. Bioconjugate Chem. 1992, 3:351-362.
15. Muggia F.M. Clin. Cancer Res. 1999, 5:7-8.
16. Vasey P.A., Kaye S.B., Morrison R., Twelves C., Wilson P., Duncan R., Thomson A.H., Murray L.S., Hilditch T.E., Murray T. Clin. Cancer Res. 1999, 5:83-94.
17. Liu R., He B., Li D., Lai Y., Chang J., Tang J.Z., Gu Z. Int. J. Nanomed. 2012, 7:4433.
18. Jones M.C., Leroux J.C. Eur. J. Pharm. Biopharm. 1999, 48:101-111.
19. A. Rösler, G.W.M. Vandermeulen and H.A. Klok, Adv Drug Delivery Rev, 64, Supplement (2012) 270-279.
20. Zhang L., Eisenberg A. Science 1995, 268:23.
21. Ulukan H., Swaan P.W. Drugs 2002, 62:2039-2057.
22. Garcia-Carbonero R., Supko J.G. Clin. Cancer Res. 2002, 8:641-661.
23. Fassberg J., Stella V.J. J. Pharm. Sci. 1992, 81:676-684.
24. Wall M.E., Wani M.C., Nicholas A.W., Manikumar G., Tele C., Moore L., Truesdale A., Leitner P., Besterman J.M. J. Med. Chem. 1993, 36:2689-2700.
25. Wani M.C., Nicholas A.W., Wall M.E. J. Med. Chem. 1987, 30:2317-2319.
26. Kingsbury W.D., Boehm J.C., Jakas D.R., Holden K.G., Hecht S.M., Gallagher G., Caranfa M.J., McCabe F.L., Faucette L.F., Johnson R.K., Hertzberg R.P. J. Med. Chem. 1991, 34:98-107.
27. Schaeppi U., Fleischman R., Cooney D. Cancer Chemother. Rep. 1974, 5:25.
28. Gao J., Ming J., He B., Fan Y., Gu Z., Zhang X. Eur. J. Pharm. Sci. 2008, 34:85-93.
29. de Groot F.M.H., Busscher G.F., Aben R.W.M., Scheeren H.W. Bioorg. Med. Chem. Lett. 2002, 12:2371-2376.
30. Lerchen H.G., Baumgarten J., von dem Bruch K., Lehmann T.E., Sperzel M., Kempka G., Fiebig H.H. J. Med. Chem. 2001, 44:4186-4195.
31. Pessah N., Reznik M., Shamis M., Yantiri F., Xin H., Bowdish K., Shomron N., Ast G., Shabat D. Bioorgan Med. Chem. 2004, 12:1859-1866.
32. Liu R., Li D., He B., Xu X., Sheng M., Lai Y., Wang G., Gu Z. J. Controlled Release 2011, 152:49-56.
33. Winnik F.M., Regismond S.T. Colloids Surf., A 1996, 118:1-39.
34. Lu J.L., Wang J.C., Zhao S.X., Liu X.Y., Zhao H., Zhang X., Zhou S.F., Zhang Q. Eur. J. Pharm. Biopharm. 2008, 69:899-907.
35. Wilhelm M., Zhao C.L., Wang Y., Xu R., Winnik M.A., Mura J.L., Riess G., Croucher M.D. Macromolecules 1991, 24:1033-1040.
36. Kumari A., Yadav S.K., Yadav S.C. Colloids Surf., B 2010, 75:1-18.
37. Zhang L.J., Xing B., Wu J., Xu B., Fang X.L. Pulm Pharmacol. Ther. 2008, 21:239-246.
38. Liang Y., Lai Y., Li D., He B., Gu Z. Mater. Lett. 2013, 97:4-7.
39. Zheng S., Chang S., Lu J., Chen Z., Xie L., Nie Y., He B., Zou S., Gu Z. PloS one 2011, 6:e21064.
40. Dong H., Dong C., Feng Y., Ren T., Zhang Z., Li L., Li Y. Med. Chem. Commun. 2012, 3:1555-1561.
41. Pramod P., Takamura K., Chaphekar S., Balasubramanian N., Jayakannan M. Biomacromolecules 2012, 13:3627-3640.